Related Experiment Video
Updated: Dec 16, 2025

06:24
High-Contrast and Fast Photorheological Switching of a Twist-Bend Nematic Liquid Crystal
Published on: October 31, 2019
6.7K
Hexaarylbiimidazoles(HABI)-functionalized lyotropic liquid crystalline systems as visible light-responsive materials
Shiyang Jia1, Bim Graham1, Ben Capuano1
1Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Parkville, VIC 3052, Australia.
Journal of Colloid and Interface Science
|July 3, 2020
Summary
Hexaarylbiimidazoles (HABIs) are novel photoswitchable molecules. These HABIs can control liquid crystal structures, enabling light-triggered "on demand" drug delivery systems.
Area of Science:
- Supramolecular Chemistry
- Materials Science
- Photochemistry
Background:
- Hexaarylbiimidazoles (HABIs) are photoswitchable molecules with limited literature.
- HABI1 exhibits negative photochromism and green light responsiveness.
- Controlling lyotropic liquid crystalline (LLC) material structure with light is an emerging area.
Purpose of the Study:
- To investigate HABIs as photo-responsive actuators for LLC materials.
- To synthesize and characterize HABI1 and HABI2 for LLC applications.
- To explore light-induced phase transitions in lipid-based systems.
Main Methods:
- Synthesis of HABI1 (methyl chains) and HABI2 (dodecyl chains).
- Time-resolved small-angle X-ray scattering (TR-SAXS) to study LLC nanostructure.
- Irradiation studies to observe HABI isomerization and LLC phase behavior.
Main Results:
- HABIs showed rapid isomerization under light and slow reversion in the dark, indicating stability.
- HABIs induced complete phase transitions in phytantriol-based LLCs.
- HABI2 caused greater disruption of lipid packing than HABI1.
- Light triggered transitions from lamellar to bicontinuous cubic phases, altering release profiles.
Conclusions:
- HABIs are effective photo-responsive actuators for LLC materials.
- The study demonstrates potential for light-controlled "on demand" drug delivery.
- Tuning HABI structure and lipid composition allows for controlled release kinetics.

